Pharmacy Diversion Awareness Conference
March 2 & 3, 2013; Hyatt Regency Albuquerque; Albuquerque, New Mexico
The Drug Enforcement Administration (DEA) held a Pharmacy Diversion Awareness Conference (PDAC) on March 2nd & 3rd, 2013 in Albuquerque, NM. This was a one-day conference, repeated on the second day, for the convenience of the pharmacy community. The conference was developed and designed to address the growing problem of diversion of pharmaceutical controlled substances throughout the United States. In addition to pharmacy robberies and thefts, pharmaceutical controlled substances are often diverted by way of forged prescriptions, doctor shoppers, or illegitimate prescriptions from rogue practitioners. The objective of this conference was to educate pharmacists, pharmacy technicians, and pharmacy loss prevention personnel on ways to address and respond to potential diversion activity.
Over 350 pharmacists, pharmacy technicians, and loss prevention personnel attended. The conference attendees received approximately seven hours of instruction on a variety of topics. The presentations included: Drug Trends, Combating Pharmacy Diversion, Drugs, Drugs and More Drugs, The PMP, Prescription Forgeries, and Pharmacy Safety, Drug Theft Prevention and CMEA Requirements & Synthetic Drug Update.
Select presentations from the Albuquerque PDAC, as well as a link to the Pharmacy Robbery & Burglary brochure, are below.
Drug Trends – Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, DEA
Combating Pharmacy Diversion – Ruth A. Carter, Chief, Import/Export Unit, Office of Diversion Control, DEA
Drugs, Drugs, and More Drugs – William T. Winsley, R.Ph., National Association of Boards of Pharmacy Representative
The PMP, Prescription Forgeries, and Pharmacy Safety – Larry Loring, Executive Director, New Mexico Board of Pharmacy
Drug Theft Prevention – Jeff Browning, Investigator, Farmington, NM Police Department
Drug Theft Prevention – Thomas Prevoznik, Staff Coordinator, Liaison and Policy Unit, Office of Diversion Control, DEA
CMEA Requirements for Retail Distributors and Synthetic Drug Update – Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, DEA